We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$457M
AUM Growth
+$26.6M
Cap. Flow
+$8.53M
Cap. Flow %
1.86%
Top 10 Hldgs %
38.17%
Holding
99
New
16
Increased
39
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$16.5M
2
RGEN icon
Repligen
RGEN
+$7.52M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$6.71M
4
NVRO
NEVRO CORP.
NVRO
+$5.59M
5
DXCM icon
DexCom
DXCM
+$4.89M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.2M
2
VCEL icon
Vericel Corp
VCEL
+$5.11M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$4.72M
4
ARWR icon
Arrowhead Research
ARWR
+$4.65M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$4.27M

Sector Composition

Rank Sector Weight
1 Healthcare 95.62%
2 Technology 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
1
Aclaris Therapeutics
ACRS
$825M
$26.4M 5.76%
1,501,460
-207,676
-12% -$4.72M
DXCM icon
2
DexCom
DXCM
$32B
$21.5M 4.71%
201,832
+50,960
+34% +$4.89M
CRL icon
3
Charles River Laboratories
CRL
$12.8B
$19.3M 4.22%
52,245
+2,245
+4% +$750K
ISRG icon
4
Intuitive Surgical
ISRG
$134B
$18M 3.94%
+58,839
New +$16.5M
UTHR icon
5
United Therapeutics
UTHR
$23.1B
$16.9M 3.7%
94,324
+19,450
+26% +$3.7M
IQV icon
6
IQVIA
IQV
$39.3B
$16.6M 3.62%
68,369
+2,321
+4% +$536K
DHR icon
7
Danaher
DHR
$144B
$15M 3.27%
62,969
-10,334
-14% -$2.29M
HUM icon
8
Humana
HUM
$46.2B
$14.5M 3.16%
32,681
-319
-1% -$139K
NTRA icon
9
Natera
NTRA
$46.1B
$13.7M 2.99%
120,547
-19,346
-14% -$1.98M
ALNY icon
10
Alnylam Pharmaceuticals
ALNY
$29.3B
$12.7M 2.78%
74,967
+9,924
+15% +$1.45M
AVTR icon
11
Avantor
AVTR
$9.19B
$12.6M 2.75%
353,941
+101,778
+40% +$3.29M
CDMO
12
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$12.2M 2.66%
475,000
-200,000
-30% -$4.27M
DRNA
13
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.4M 2.49%
304,686
+1,418
+0.5% +$43.5K
PODD icon
14
Insulet
PODD
$9.79B
$9.7M 2.12%
35,340
+4,171
+13% +$1.13M
ICAD
15
DELISTED
iCAD Inc
ICAD
$9.2M 2.01%
531,255
-116,876
-18% -$2.05M
ITMR
16
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$7.96M 1.74%
338,001
+1,572
+0.5% +$35.1K
RGEN icon
17
Repligen
RGEN
$9.25B
$7.73M 1.69%
+38,740
New +$7.52M
XLRN
18
DELISTED
Acceleron Pharma
XLRN
$7.54M 1.65%
60,074
-2,706
-4% -$341K
XENE icon
19
Xenon Pharmaceuticals
XENE
$6.12B
$7.47M 1.63%
401,207
+26,812
+7% +$494K
COO icon
20
Cooper Companies
COO
$14.5B
$7.37M 1.61%
74,352
+44,352
+148% +$4.35M
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
$7.13M 1.56%
+45,176
New +$6.71M
XRAY icon
22
Dentsply Sirona
XRAY
$2.43B
$6.99M 1.53%
110,455
+60,455
+121% +$3.98M
RCUS icon
23
Arcus Biosciences
RCUS
$3.64B
$6.77M 1.48%
246,637
-69,245
-22% -$1.98M
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.77M 1.48%
72,267
+3,837
+6% +$353K
STXS icon
25
Stereotaxis
STXS
$141M
$6.55M 1.43%
679,082
+3,160
+0.5% +$24.9K
1
2 3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Parkman Healthcare Partners held 99 positions worth $457M, up 6.2% from $431M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Parkman Healthcare Partners's Q2 2021 filing shows 16 new, 39 increased, 27 reduced and 17 closed positions. Its largest new stake was Intuitive Surgical: 58,839 shares worth $18M. The largest sale was Amgen, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 92% a quarter earlier, followed by Technology.

  • Parkman Healthcare Partners's largest Q2 2021 buy was Intuitive Surgical: 58,839 shares worth $18M.
  • Parkman Healthcare Partners added most to DexCom in Q2 2021, an estimated $4.89M increase.
  • Parkman Healthcare Partners's biggest Q2 2021 reduction was Vericel Corp, cutting an estimated $5.11M.
  • Parkman Healthcare Partners fully exited Amgen in Q2 2021, selling an estimated $11.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 38% of its $457M portfolio in Q2 2021.
  • Parkman Healthcare Partners opened 16 new positions and closed 17 in Q2 2021.
  • Parkman Healthcare Partners's portfolio value rose 6.2% quarter-over-quarter to $457M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.